JP2008532014A5 - - Google Patents

Download PDF

Info

Publication number
JP2008532014A5
JP2008532014A5 JP2007557159A JP2007557159A JP2008532014A5 JP 2008532014 A5 JP2008532014 A5 JP 2008532014A5 JP 2007557159 A JP2007557159 A JP 2007557159A JP 2007557159 A JP2007557159 A JP 2007557159A JP 2008532014 A5 JP2008532014 A5 JP 2008532014A5
Authority
JP
Japan
Prior art keywords
useful
epitopes
epitopes according
useful epitopes
nisch
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2007557159A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008532014A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2006/006431 external-priority patent/WO2006091734A2/en
Publication of JP2008532014A publication Critical patent/JP2008532014A/ja
Publication of JP2008532014A5 publication Critical patent/JP2008532014A5/ja
Withdrawn legal-status Critical Current

Links

JP2007557159A 2005-02-24 2006-02-24 生物試料を分類するための組成物及び方法 Withdrawn JP2008532014A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65685905P 2005-02-24 2005-02-24
PCT/US2006/006431 WO2006091734A2 (en) 2005-02-24 2006-02-24 Compositions and methods for classifying biological samples

Publications (2)

Publication Number Publication Date
JP2008532014A JP2008532014A (ja) 2008-08-14
JP2008532014A5 true JP2008532014A5 (enExample) 2009-04-16

Family

ID=36928007

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007557159A Withdrawn JP2008532014A (ja) 2005-02-24 2006-02-24 生物試料を分類するための組成物及び方法

Country Status (11)

Country Link
US (1) US20090075832A1 (enExample)
EP (1) EP1859266A4 (enExample)
JP (1) JP2008532014A (enExample)
KR (1) KR20080003321A (enExample)
CN (1) CN101160524A (enExample)
AU (1) AU2006216683A1 (enExample)
CA (1) CA2598889A1 (enExample)
IL (1) IL185458A0 (enExample)
MX (1) MX2007010349A (enExample)
RU (1) RU2007135030A (enExample)
WO (1) WO2006091734A2 (enExample)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060222656A1 (en) 2005-04-01 2006-10-05 University Of Maryland, Baltimore MAGE-A3/HPV 16 peptide vaccines for head and neck cancer
US7842480B2 (en) 2001-05-18 2010-11-30 Mayo Foundation For Medical Education And Research Chimeric antigen-specific t cell-activating polypeptides
CA2655933C (en) * 2006-06-23 2014-09-09 Alethia Biotherapeutics Inc. Polynucleotides and polypeptide sequences involved in cancer
WO2008053573A1 (fr) * 2006-10-30 2008-05-08 National University Corporation Hokkaido University Remède pour néoplasme malin
TWI494319B (zh) * 2007-02-21 2015-08-01 Oncotherapy Science Inc 表現腫瘤相關抗原之癌症的胜肽疫苗
US8715684B2 (en) 2007-08-28 2014-05-06 Ramot At Tel Aviv University Ltd. Peptides inducing a CD4i conformation in HIV gp120 while retaining vacant CD4 binding site
TWI466680B (zh) 2008-08-01 2015-01-01 Oncotherapy Science Inc Ｍｅｌｋ抗原決定位胜肽及含此胜肽的疫苗
TW201008574A (en) 2008-08-19 2010-03-01 Oncotherapy Science Inc INHBB epitope peptides and vaccines containing the same
CN104829714A (zh) 2008-11-03 2015-08-12 阿莱斯亚生物疗法股份有限公司 特异性地阻滞肿瘤抗原的生物活性的抗体
GB0823366D0 (en) * 2008-12-22 2009-01-28 Uni I Oslo Synthesis
KR101067815B1 (ko) * 2009-02-05 2011-09-27 서울대학교산학협력단 제1형 당뇨병의 신규한 진단 마커
EP3444613B1 (en) 2009-08-14 2021-05-19 The Regents of The University of California Methods of diagnosing and treating autism
US8075895B2 (en) * 2009-09-22 2011-12-13 Janssen Pharmaceutica N.V. Identification of antigenic peptides from multiple myeloma cells
TWI485245B (zh) 2010-01-25 2015-05-21 Oncotherapy Science Inc 經修飾之ｍｅｌｋ胜肽及含此胜肽之疫苗
CA2893376A1 (en) 2011-03-31 2012-10-04 Alethia Biotherapeutics Inc. Antibodies against kidney associated antigen 1 and antigen binding fragemnts thereof
US10060911B2 (en) * 2011-08-19 2018-08-28 Protagen Aktiengesellschaft Method for diagnosis of high-affinity binders and marker sequences
WO2013031757A1 (ja) * 2011-08-29 2013-03-07 東レ株式会社 膵癌、乳癌、肺癌又は前立腺癌の検出用マーカー及び検査方法
AU2013209234B2 (en) 2012-01-09 2017-11-09 Adc Therapeutics Sa Method for treating breast cancer
US20130183242A1 (en) * 2012-01-18 2013-07-18 University Of Connecticut Methods for identifying tumor-specific polypeptides
GB201319446D0 (en) * 2013-11-04 2013-12-18 Immatics Biotechnologies Gmbh Personalized immunotherapy against several neuronal and brain tumors
WO2015172843A1 (en) * 2014-05-16 2015-11-19 Biontech Diagnostics Gmbh Methods and kits for the diagnosis of cancer
US20150335679A1 (en) * 2014-05-20 2015-11-26 Kiromic, Llc Methods and Compositions for Treating Malignancies with Dendritic Cells
EP3247407A4 (en) 2015-01-21 2018-08-22 Inhibrx LP Non-immunogenic single domain antibodies
GB201505305D0 (en) * 2015-03-27 2015-05-13 Immatics Biotechnologies Gmbh Novel Peptides and combination of peptides for use in immunotherapy against various tumors
MX393605B (es) 2015-06-26 2025-03-24 Univ California Peptidos antigenicos y usos de los mismos para diagnosticar y tratar el autismo
JP6807606B2 (ja) 2015-07-16 2021-01-06 インヒブルクス インコーポレイテッド 多価及び多重特異性ｄｒ５結合融合タンパク質
PH12022551111A1 (en) 2015-10-05 2023-08-23 Immatics Biotechnologies Gmbh Peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancers
EP3193173A1 (en) * 2016-01-14 2017-07-19 Deutsches Krebsforschungszentrum, Stiftung des öffentlichen Rechts Serological autoantibodies as biomarker for colorectal cancer
GB201604458D0 (en) 2016-03-16 2016-04-27 Immatics Biotechnologies Gmbh Peptides and combination of peptides for use in immunotherapy against cancers
DE102016123893A1 (de) 2016-12-08 2018-06-14 Immatics Biotechnologies Gmbh T-Zellrezeptoren mit verbesserter Bindung
AU2018212584B2 (en) * 2017-01-27 2020-12-10 Immatics Biotechnologies Gmbh Novel peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
CN108948184B (zh) * 2017-05-22 2021-04-23 香雪生命科学技术（广东）有限公司 一种识别衍生自prame抗原短肽的t细胞受体
CN109400697B (zh) * 2017-08-17 2021-04-23 香雪生命科学技术（广东）有限公司 一种识别prame抗原短肽的tcr及其相关组合物
EP3756680A1 (en) * 2019-06-26 2020-12-30 Universitat de Lleida Intermediate filament-derived peptides and their uses
EP3999525A4 (en) * 2019-07-15 2023-08-09 Geisinger Health System COMPOSITIONS AND METHODS FOR THE TREATMENT OF BREAST CANCER WITH A NOVEL CAPER ALPHA MLL1 COMPLEX
CN110922492B (zh) * 2019-12-18 2022-02-15 重庆医科大学 融合肽、ctp介导的诱导cml细胞免疫应答的dc疫苗及其制备方法
CN111337678B (zh) * 2020-02-21 2023-06-06 杭州凯保罗生物科技有限公司 与肿瘤免疫治疗效果相关的生物标志物及其应用
GB202103200D0 (en) * 2021-03-08 2021-04-21 Terasom S R O Lung Cancer diagnosis
CN116773798B (zh) * 2023-06-16 2026-04-17 北京三品医疗科技有限公司 多肽的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7625697B2 (en) * 1994-06-17 2009-12-01 The Board Of Trustees Of The Leland Stanford Junior University Methods for constructing subarrays and subarrays made thereby
EP1337667A2 (en) * 2000-11-16 2003-08-27 Cedars-Sinai Medical Center Profiling tumor specific markers for the diagnosis and treatment of neoplastic disease
WO2002073209A2 (de) * 2001-03-10 2002-09-19 Affina Immuntechnik Gmbh Verfahren zur identifikation von immunreaktiven epitopen auf proteinen
EP1386155A4 (en) * 2001-04-10 2006-05-10 Univ Leland Stanford Junior THERAPEUTIC AND DIAGNOSTIC USE OF ANTIBODY SPECIFICITY PROFILES
EP1434860A2 (en) * 2001-09-28 2004-07-07 Incyte Genomics, Inc. Enzymes
EP1578970A1 (de) * 2002-12-23 2005-09-28 Hans-Jürgen Thiesen Human-autoantigene und deren verwendung
EP1583504A4 (en) * 2002-12-26 2008-03-05 Cemines Llc METHOD AND COMPOSITIONS FOR DIAGNOSIS, FORECAST AND TREATMENT OF CANCER

Similar Documents

Publication Publication Date Title
RU2007135030A (ru) Композиции и способы классификации биологических образцов
Makretsov et al. Hierarchical clustering analysis of tissue microarray immunostaining data identifies prognostically significant groups of breast carcinoma
CN103826750B (zh) 从血液中捕获和检测循环多发性骨髓瘤的测定法
JP2012508865A5 (enExample)
CN106650312B (zh) 一种用于循环肿瘤dna拷贝数变异检测的装置
JP2009538607A5 (enExample)
Caprioli Deciphering protein molecular signatures in cancer tissues to aid in diagnosis, prognosis, and therapy
Los-de Vries et al. Genomic and microenvironmental landscape of stage I follicular lymphoma, compared with stage III/IV
Brunt et al. Biphenotypic (hepatobiliary) primary liver carcinomas: the work in progress
Mok et al. Association of kidney disease measures with cause-specific mortality: the Korean Heart Study
JP2009522578A5 (enExample)
JP2015518152A (ja) 前立腺がんの検出用バイオマーカーの定量
Colomo et al. LMO2-negative expression predicts the presence of MYC translocations in aggressive B-cell lymphomas
JP2017195803A (ja) 早期胃癌検出キット及び早期胃癌細胞の検出方法
WO2015007625A1 (en) Method for the prognosis of survival time of a patient suffering from a solid cancer
Hofman Liquid biopsy for lung cancer screening: usefulness of circulating tumor cells and other circulating blood biomarkers
Zhu et al. Liquid biopsy screening for early detection of lung cancer: current state and future directions
JP2016531596A (ja) 循環している癌のバイオマーカー及びその使用
JP2010526995A5 (enExample)
Benhammou et al. DETECT: development of technologies for early HCC detection
Harris et al. Quest for the ideal cancer biomarker: an update on progress in capture and characterization of circulating tumor cells
Andreadis et al. Metastatic renal clear cell carcinoma in the parotid gland: a study of immunohistochemical profile and cell adhesion molecules (CAMs) expression in two cases
Bofin et al. Papanicolaou smear history in women with low‐grade cytology before cervical cancer diagnosis
Rivera-Mariani et al. Skin test reactivity of allergic subjects to basidiomycetes' crude extracts in a tropical environment
JP2013513812A5 (enExample)